Sintesi e caratterizzazione di un profarmaco Aspirina-fumarato che inibisce NFκB attività e della mammella cellule tumorali staminali

1:13

Synthesis of Aspirin-fumarate Prodrug, GTCpFE

6:10

Inhibiting the NFκB Activity with GTCpFE in Breast Cancer Cells

7:22

Inhibiting Breast Cancer Stem Cells with GTCpFE In Vitro

10:11

Results: GTCpFE Inhibits the NFκB Pathway, Mammosphere Formation, and the CD44⁺CD24^- Immunophenotype in Breast Cancer Cells

11:49

Conclusion